Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1998 1
2011 1
2015 3
2016 2
2017 2
2018 3
2019 1
2020 1
2021 1
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency"
Page 1
Polyarteritis nodosa.
Bilginer Y, Ozen S. Bilginer Y, et al. Curr Opin Pediatr. 2022 Apr 1;34(2):229-233. doi: 10.1097/MOP.0000000000001106. Curr Opin Pediatr. 2022. PMID: 35081554 Review.
Unfortunately, we lack large patient numbers to provide us high evidence for the treatment of these patients. However, for induction mycophenolate mofetil or shorter courses of cyclophosphamide can be considered.Deficiency of ADA2 is now in the differential diagnosis of po …
Unfortunately, we lack large patient numbers to provide us high evidence for the treatment of these patients. However, for induction mycophe …
Severe combined immunodeficiency diagnosis and genetic defects.
Aranda CS, Gouveia-Pereira MP, da Silva CJM, Rizzo MCFV, Ishizuka E, de Oliveira EB, Condino-Neto A. Aranda CS, et al. Immunol Rev. 2024 Mar;322(1):138-147. doi: 10.1111/imr.13310. Epub 2024 Jan 29. Immunol Rev. 2024. PMID: 38287514 Review.
With this respect, newborn screening is progressively and dramatically improving the prognosis of SCID....
With this respect, newborn screening is progressively and dramatically improving the prognosis of SCID....
How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
Kohn DB, Gaspar HB. Kohn DB, et al. J Clin Immunol. 2017 May;37(4):351-356. doi: 10.1007/s10875-017-0373-y. Epub 2017 Feb 14. J Clin Immunol. 2017. PMID: 28194615 Review.
Adenosine deaminase-deficient severe combined immune deficiency (ADA SCID) accounts for 10-15% of cases of human SCID. From what was once a uniformly fatal disease, the prognosis for infants with ADA SCID has improved greatly based on the development of multiple therapeuti …
Adenosine deaminase-deficient severe combined immune deficiency (ADA SCID) accounts for 10-15% of cases of human SCID. From what was once a …
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report.
Oster C, Stolte B, Asan L, Pul R, Klebe S, Köhrmann M, Breuckmann K, Rischpler C, Deuschl C, Dolff S, Kleinschnitz C, Hagenacker T. Oster C, et al. J Clin Immunol. 2023 Oct;43(7):1597-1602. doi: 10.1007/s10875-023-01526-3. Epub 2023 Jun 12. J Clin Immunol. 2023. PMID: 37306896 Free PMC article.
METHODS: Case report and detailed description of the clinical course of diagnosis and treatment. CASE: The patient's medical history consisted of an unknown immunodeficiency syndrome. ...This stroke etiology is rare but should be considered as a cause of recurrent stroke o …
METHODS: Case report and detailed description of the clinical course of diagnosis and treatment. CASE: The patient's medical history …
National experience with adenosine deaminase deficiency related SCID in Polish children.
Dąbrowska-Leonik N, Piątosa B, Słomińska E, Bohynikova N, Bernat-Sitarz K, Bernatowska E, Wolska-Kuśnierz B, Kałwak K, Kołtan S, Dąbrowska A, Goździk J, Ussowicz M, Pac M. Dąbrowska-Leonik N, et al. Front Immunol. 2023 Jan 6;13:1058623. doi: 10.3389/fimmu.2022.1058623. eCollection 2022. Front Immunol. 2023. PMID: 36685585 Free PMC article.
Untreated patients develop immune and non-immune symptoms with fatal clinical course. According to ESID and EBMT recommendations enzyme replacement therapy (ERT) should be implemented as soon as possible to stabilize the patient's general condition, normalize transaminases …
Untreated patients develop immune and non-immune symptoms with fatal clinical course. According to ESID and EBMT recommendations enzy …
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy.
Bradford KL, Liu S, Krajinovic M, Ansari M, Garabedian E, Tse J, Wang X, Shaw KL, Gaspar HB, Candotti F, Kohn DB. Bradford KL, et al. Biol Blood Marrow Transplant. 2020 Oct;26(10):1819-1827. doi: 10.1016/j.bbmt.2020.07.004. Epub 2020 Jul 9. Biol Blood Marrow Transplant. 2020. PMID: 32653625 Free PMC article.
However, weight and age alone were insufficient to accurately predict the dose that would consistently achieve a target AUC. Furthermore, various clinical, laboratory, and genetic factors (eg, genotypes for glutathione-S-transferase isozymes known to participate in BU meta …
However, weight and age alone were insufficient to accurately predict the dose that would consistently achieve a target AUC. Furtherm …
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.
Reinhardt B, Habib O, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Terrazas D, Fernandez BC, De Oliveira S, Moore TB, Ikeda AK, Engel BC, Podsakoff GM, Hollis RP, Fernandes A, Jackson C, Shupien S, Mishra S, Davila A, Mottahedeh J, Vitomirov A, Meng W, Rosenfeld AM, Roche AM, Hokama P, Reddy S, Everett J, Wang X, Luning Prak ET, Cornetta K, Hershfield MS, Sokolic R, De Ravin SS, Malech HL, Bushman FD, Candotti F, Kohn DB. Reinhardt B, et al. Blood. 2021 Oct 14;138(15):1304-1316. doi: 10.1182/blood.2020010260. Blood. 2021. PMID: 33974038 Free PMC article. Clinical Trial.
21 results